TETHERED ALKYLIDENES FROM ORGANOAZIDES FOR CYCLIC POLYMER SYNTHESIS
20250043067 ยท 2025-02-06
Inventors
Cpc classification
C08G61/08
CHEMISTRY; METALLURGY
International classification
Abstract
Provided herein are catalysts for polymerization of linear alkynes to cyclic poly(alkynes), and methods of making and using same. For example, provided herein are compounds of formula (I), or dimers thereof:
##STR00001##
Claims
1. A catalyst having a structure represented by formula (I), or dimers thereof: ##STR00027## wherein M is a transition metal; L is absent or selected from the group of NH.sub.3, N(R.sup.5).sub.3, Ar.sup.1, C.sub.1-6hydroxyalkyl, NCR.sup.5, NC(R.sup.5).sub.2, OR.sup.5, O(R.sup.5).sub.2, P(R.sup.5).sub.3, P(OR.sup.5).sub.3, PR.sup.5(OR.sup.5).sub.2, PR.sup.5.sub.2(OR.sup.5), R.sup.5(CO)N(R.sup.5).sub.2, R.sup.5(CO)NHR.sup.5, R.sup.5CHO, R.sup.5COR.sup.5, R.sup.5COOR.sup.5, SR.sup.5, and S(R.sup.5).sub.2; R.sup.1 is selected from H, NNR.sup.a, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, Si(R.sup.5).sub.3, and Ar.sup.1, and R.sup.a is selected from H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, and Ar.sup.1; R.sup.2 is selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-20haloalkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1).sub.2, OH, OAr.sup.1, and O(C.sub.1-C.sub.20alkyl); each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, OAr.sup.1, O(C.sub.1-C.sub.20alkyl), and OH, or R.sup.3 together with an adjacent R.sup.4 and the carbon atoms to which they are attached form a five- to eight-membered cyclic group; each m is independently 0, 1, 2, or 3; each R.sup.4 is independently selected from Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, halo, and OH, or two adjacent R.sup.4, together with the carbon atoms to which they are attached, can form a five- to eight-membered cyclic group; each R.sup.5 is independently selected from H, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, Ar.sup.1, or two R.sup.5, together with the atoms to which they are attached, form a five- to eight-membered heterocycle comprising from 1 to 3 ring heteroatoms selected from O, N, and S; and each Ar.sup.1 is independently selected from C.sub.0-C.sub.3alkylene-C.sub.6-20 aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S.
2. The catalyst of claim 1, wherein M comprises a group 6 transition metal.
3. The catalyst of claim 2, wherein M is chromium (Cr), molybdenum (Mo), or tungsten (W).
4. (canceled)
5. The catalyst of claim 1, wherein R.sup.2 is H, Ar.sup.1, C.sub.1-C.sub.20 alkyl, C.sub.5-C.sub.8cycloalkyl, or C.sub.1-C.sub.20haloalkyl.
6. (canceled)
7. The catalyst of claim 5, wherein R.sup.2 is tert-butyl.
8. The catalyst of claim 1, wherein each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, and OH.
9. The catalyst of claim 8, wherein each R.sup.3 is independently H, Ar.sup.1, C.sub.1-C.sub.22 haloalkyl or C.sub.1-C.sub.20alkyl.
10. The catalyst of claim 1, wherein R.sup.3 is tert-butyl, C.sub.6-20aryl, or C.sub.1-3alkylene-C.sub.6-20aryl.
11. (canceled)
12. The catalyst of claim 1, wherein each R.sup.4 is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, Ar.sup.1, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, halo, C.sub.1-C.sub.20haloalkyl, and OH.
13. The catalyst of claim 12, wherein each R.sup.4 is C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, C.sub.1-C.sub.20haloalkyl, C.sub.6-20aryl, or C.sub.1-3 alkylene-C.sub.5-20 aryl.
14.-15. (canceled)
16. The catalyst of claim 1, wherein L is Ar.sup.1, N(R.sup.5).sub.3, P(R.sup.5).sub.3, S(R.sup.5).sub.2 or O(R.sup.5).sub.2.
17. The catalyst of claim 16, wherein each R.sup.5 of L is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, and Ar.sup.1C.sub.6-20aryl, and C.sub.1-3alkyleneC.sub.6-20 aryl.
18. (canceled)
19. The catalyst of claim 1, wherein L is tetrahydrofuran (THF), pyridine, or thiophene.
20. The catalyst of claim 1, wherein R.sup.1 is selected from the group consisting of H, C.sub.1-20alkyl, C.sub.3-8cycloalkyl, and Ar.sup.1.
21. The catalyst of claim 1, wherein R.sup.1 is H, NNR.sup.a, C.sub.1-20alkyl, C.sub.3-8 cycloalkyl, or Ar.sup.1.
22. The catalyst of claim 21, wherein each Ar.sup.1 of R.sup.1 is C.sub.0-C.sub.3alkylene-C.sub.6-20 aryl.
23. The catalyst of claim 1, wherein R.sup.1 is phenyl, C.sub.8alkyl, C.sub.6cycloalkyl, or benzyl.
24. The catalyst of claim 21, wherein R.sup.1 is NNR.sup.a, and R.sup.a is C.sub.1-C.sub.22 alkyl, C.sub.3-8 cycloalkyl, C.sub.6-20aryl, or C.sub.1-3alkylene-C.sub.6-20aryl.
25.-26. (canceled)
27. A method for making the catalyst of claim 1, comprising reacting a compound of formula (II) and an organoazide having a structure of formula (III) under conditions sufficient to form the catalyst: ##STR00028## wherein in formula (II): M is a transition metal; each L is independently absent or selected from the group of NH.sub.3, N(R.sup.5).sub.3, Ar.sup.1, C.sub.1-6hydroxyalkyl, NCR.sup.5, NC(R.sup.5).sub.2, OR.sup.5, O(R.sup.5).sub.2, P(R.sup.5).sub.3, P(OR.sup.5).sub.3, PR.sup.5(OR.sup.5).sub.2, PR.sup.5.sub.2(OR.sup.5), R.sup.5(CO)N(R.sup.5).sub.2, R.sup.5(CO)NHR.sup.5, R.sup.5CHO, R.sup.5COR.sup.5, R.sup.5COOR.sup.5, SR.sup.5, and S(R.sup.5).sub.2; R.sup.2 is selected from H, Ar.sup.1, C.sub.1-20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-20haloalkyl, NH.sub.2, N(C.sub.1-22 alkyl).sub.2, NH(C.sub.1-22 alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, OH, OAr.sup.1, O(C.sub.1-22 alkyl), and Si(R.sup.5).sub.3; each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-20alkyl, NH.sub.2, N(C.sub.1-20alkyl).sub.2, NH(C.sub.1-20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, OAr.sup.1, O(C.sub.1-20alkyl), and OH, or R.sup.3 together with an adjacent R.sup.4 and the carbon atoms to which they are attached form a five- to eight-membered cyclic group; each R.sup.4 is independently selected from Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-20alkyl, NH.sub.2, N(C.sub.1-20alkyl).sub.2, NH(C.sub.1-20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, halo, and OH, or two adjacent R.sup.4, together with the carbon atoms to which they are attached, can form a five- to eight-membered cyclic group; each R.sup.5 is independently selected from H, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, Ar.sup.1, or two R.sup.5, together with the atoms to which they are attached, form a five- to eight-membered heterocycle comprising from 1 to 3 ring heteroatoms selected from O, N, and S; and each Ar.sup.1 is independently selected from C.sub.6-20aryl, C.sub.1-3alkylene-C.sub.6-20aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S; and each m is independently 0, 1, 2, or 3; and wherein in formula (III): R is selected from H, C.sub.1-20alkyl, C.sub.3-8cycloalkyl, Si(R.sup.5).sub.3, and Ar.sup.1.
28.-34. (canceled)
35. A method of preparing a cyclic polymer, comprising: admixing a plurality of alkene monomers, alkyne monomers, or both in the presence of the catalyst of formula (I), or dimer thereof, of claim 1 under conditions sufficient to polymerize the plurality of alkene monomers, alkyne monomers, or both to form the cyclic polymer, wherein the cyclic polymer ring comprises alkene groups.
36.-44. (canceled)
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
DETAILED DESCRIPTION
[0039] Provided herein are compounds having a structure represented by formula (I) and methods of making and using said compounds. In embodiments, compounds having a structure represented by formula (I) can be in the form of a dimer. Compounds having a structure represented by formula (I), and dimers thereof, can be used as a catalyst in the preparation of cyclic polymers. Advantageously, compounds having a structure represented by formula (I), or dimers thereof, can generate high-molecular weight cyclic polyalkenes.
[0040] The compounds of the disclosure have structures represented by formulas (I), (II), and (III), and these compounds may also be referred to as compounds of formula (I), compounds of formula (II), and compounds of formula (III), herein, respectively. The compounds of formula (I) may also be referred to as a catalyst of formula (I) throughout the disclosure.
[0041] It is to be understood that the terminology used herein is to describe particular aspects only and is not intended to be limiting. As used in the specification and the claims, the term comprising can include the aspect of consisting of. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the disclosed compositions and methods belong. In this specification and in the claims which follow, reference will be made to several terms which shall be defined herein.
[0042] As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure. Any recited method can be carried out in the order of events described or in any other order that is logically possible.
[0043] The use of the terms a, an, the, and similar referents in the context of the disclosure herein (especially in the context of the claims) are to be construed to cover both the singular and the plural, unless otherwise indicated. Recitation of ranges of values herein merely are intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. The use of any and all examples, or exemplary language (e.g., such as) provided herein, is intended to better illustrate the disclosure herein and is not a limitation on the scope of the disclosure herein unless otherwise indicated. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the disclosure herein.
Definitions
[0044] As used herein, the term alkyl refers to straight chained and branched saturated hydrocarbon groups containing one to thirty carbon atoms, for example, one to twenty two carbon atoms, or one to twenty carbon atoms, or one to ten carbon atoms. The term Cn means the alkyl group has n carbon atoms. For example, C.sub.4 alkyl refers to an alkyl group that has 4 carbon atoms. C.sub.1-7alkyl and C.sub.1-C.sub.7 alkyl refer to an alkyl group having a number of carbon atoms encompassing the entire range (i.e., 1 to 7 carbon atoms), as well as all subgroups (e.g., 1-6, 2-7, 1-5, 3-6, 1, 2, 3, 4, 5, 6, and 7 carbon atoms). Nonlimiting examples of alkyl groups include, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl (2-methylpropyl), t-butyl (1,1-dimethylethyl), 3,3-dimethylpentyl, and 2-ethylhexyl. Unless otherwise indicated, an alkyl group can be an unsubstituted alkyl group or a substituted alkyl group. The term alkylene refers to an alkyl group that is further substituted, e.g., alkylene-aryl refers to an alkyl group having an aryl substituent.
[0045] As used herein, the term cycloalkyl refers to an aliphatic cyclic hydrocarbon group containing three to eight carbon atoms (e.g., 3, 4, 5, 6, 7, or 8 carbon atoms). The term Cn means the cycloalkyl group has n carbon atoms. For example, C.sub.5 cycloalkyl refers to a cycloalkyl group that has 5 carbon atoms in the ring. C.sub.5-8 cycloalkyl and C.sub.5-C.sub.8 cycloalkyl refer to cycloalkyl groups having a number of carbon atoms encompassing the entire range (i.e., 5 to 8 carbon atoms), as well as all subgroups (e.g., 5-6, 6-8, 7-8, 5-7, 5, 6, 7, and 8 carbon atoms). Nonlimiting examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Unless otherwise indicated, a cycloalkyl group can be an unsubstituted cycloalkyl group or a substituted cycloalkyl group. The cycloalkyl groups described herein can be isolated or fused to another cycloalkyl group, a heterocycle group, an aryl group and/or a heteroaryl group.
[0046] As used herein, the term heterocycle is defined similarly as cycloalkyl, except the ring contains one to three heteroatoms independently selected from oxygen, nitrogen, and sulfur. In particular, the term heterocycle refers to a ring containing a total of three to eight atoms, of which 1, 2, 3 or three of those atoms are heteroatoms independently selected from the group consisting of oxygen, nitrogen, and sulfur, and the remaining atoms in the ring are carbon atoms. Nonlimiting examples of heterocycle groups include piperdine, tetrahydrofuran, tetrahydropyran, dihydrofuran, morpholine, and the like. Heterocycle groups can be saturated or partially unsaturated ring systems optionally substituted with, for example, one to three groups, independently selected alkyl, alkenyl, OH, C(O)NH.sub.2, NH.sub.2, oxo (O), aryl, haloalkyl, halo, and OH. Heterocycle groups optionally can be further N-substituted with alkyl, hydroxyalkyl, alkylene-aryl, and alkylene-heteroaryl. The heterocycle groups described herein can be isolated or fused to another heterocycle group, a cycloalkyl group, an aryl group, and/or a heteroaryl group. When a heterocycle group is fused to another heterocycle group, then each of the heterocycle groups can contain three to eight total ring atoms, and one to three heteroatoms. In some embodiments, the heterocycle groups described herein comprise one oxygen ring atom (e.g., oxiranyl, oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl).
[0047] As used herein, the term aryl refers to monocyclic or polycyclic (e.g., fused bicyclic and fused tricyclic) carbocyclic aromatic ring systems. Examples of aryl groups include, but are not limited to, phenyl, naphthyl, tetrahydronaphthyl, phenanthrenyl, biphenylenyl, indanyl, indenyl, anthracenyl, and fluorenyl. Unless otherwise indicated, an aryl group can be an unsubstituted aryl group or a substituted aryl group.
[0048] As used herein, the term heteroaryl refers to a cyclic aromatic ring having five to twelve total ring atoms (e.g., a monocyclic aromatic ring with 5-6 total ring atoms), and containing one to three heteroatoms selected from nitrogen, oxygen, and sulfur in the aromatic ring. Unless otherwise indicated, a heteroaryl group can be unsubstituted or substituted with one or more, and in particular one to four, substituents selected from, for example, halo, alkyl, alkenyl, OCF.sub.3, NO.sub.2, CN, NC, OH, alkoxy, amino, CO.sub.2H, CO.sub.2alkyl, aryl, and heteroaryl. In some cases, the heteroaryl group is substituted with one or more of alkyl and alkoxy groups. Heteroaryl groups can be isolated (e.g., pyridyl) or fused to another heteroaryl group (e.g., purinyl), a cycloalkyl group (e.g., tetrahydroquinolinyl), a heterocycle group (e.g., dihydronaphthyridinyl), and/or an aryl group (e.g., benzothiazolyl and quinolyl). Examples of heteroaryl groups include, but are not limited to, thienyl, furyl, pyridyl, pyrrolyl, oxazolyl, quinolyl, thiophenyl, isoquinolyl, indolyl, triazinyl, triazolyl, isothiazolyl, isoxazolyl, imidazolyl, benzothiazolyl, pyrazinyl, pyrimidinyl, thiazolyl, and thiadiazolyl. When a heteroaryl group is fused to another heteroaryl group, then each ring can contain five or six total ring atoms and one to three heteroatoms in its aromatic ring.
[0049] As used herein, the term cyclic group refers to any ring structure comprising a cycloalkyl, heterocycle, aryl, heteroaryl, or a combination thereof. Unless otherwise indicated, a cyclic group can be an unsubstituted or a substituted cyclic group.
[0050] As used herein, the term hydroxy or hydroxyl refers to the OH group. As used herein, the term thiol refers to the SH group. As used herein, the term hydroxyalkyl refers to an alkyl group in which one or more of the hydrogen atoms are replaced by a hydroxyl group (OH). Such groups include but are not limited to, hydroxymethyl, hydroxyethyl, and the like.
[0051] As used herein, the term alkoxy or alkoxyl refers to a O-alkyl group. As used herein, the term aryloxy or aryloxyl refers to a O-aryl group.
[0052] As used herein, the term ether refers to an alkyl-O-alkyl group. The alkyl groups can together form a ring. A C.sub.2-C.sub.22 ether refers to an ether group wherein both alkyl groups together, or a ring formed therefrom have 2 to 22 carbons. When provided as a ligand, the ether can be coordinated to the metal center through the oxygen. As used herein, the term thioether is defined similarly to ether except the oxygen atom is replaced with a sulfur atom. As used herein, the term polyether refers to a ether-(O-ether).sub.n group, where n is greater than or equal to 1. As used herein, the term polythioether is defined similarly to ether except the oxygen atom is replaced with a sulfur atom.
[0053] As used herein, the term halo is defined as fluoro, chloro, bromo, and iodo. The term haloalkyl refers to an alkyl group that is substituted with at least one halogen, and includes perhalogenated alkyl (i.e., all hydrogen atoms substituted with halogen).
[0054] As used herein, the term carboxy or carboxyl refers to a COOH group.
[0055] As used herein, the term amino refers to a NH.sub.2 group, wherein one or both hydrogen can be replaced with an alkyl, cycloalkyl, or aryl group. As used herein, the term amido refers to an amino group that is substituted with a carbonyl moiety (e.g., NRC(O) or OC(O)NR), wherein R is a substituent on the nitrogen (e.g., alkyl or H). When referring to a ligand, the term amine refers to a NH.sub.3 group, where one, two, or three hydrogen can be replaced with an alkyl, cycloalkyl, or aryl group. When referring to a ligand, the term amide refers to a NR.sub.2 group, wherein each R is independently a hydrogen, alkyl, cycloalkyl, or aryl group. As used herein imine refers to a N(R)CR.sub.2 group, wherein each R is independently an alkyl, cycloalkyl, or aryl group.
[0056] As used herein, the term phosphine refers to a PH.sub.3 group, wherein one, two or three hydrogen can be replaced with an alkyl, cycloalkyl, or aryl group. As used herein phosphite refers to a P(OR).sub.3 group, wherein each R can individually be alkyl, cycloalkyl, or aryl. As used herein, phosphonite refers to a PR(OR).sub.2 group, wherein each R can individually be alkyl, cycloalkyl, or aryl. As used herein, phosphinite refers to a PR.sub.2(OR) group, wherein each R can individually be alkyl, cycloalkyl, or aryl.
[0057] As used herein, the term ester refers to a C(O)OR group, wherein R is a substituent on the oxygen (e.g., alkyl or aryl).
[0058] As used herein, the term substituted, when used to modify a chemical functional group, refers to the replacement of at least one hydrogen radical on the functional group with a substituent. Substituents can include, but are not limited to, alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, heterocycle, ether, polyether, thioether, polythioether, aryl, heteroaryl, hydroxyl, oxo (O), alkoxy, heteroalkoxy, aryloxy, heteroaryloxy, ester, thioester, carboxy, cyano, nitro, amino, amido, amide, and halo (e.g., fluoro, chloro, bromo, or iodo). When a chemical functional group includes more than one substituent, the substituents can be bound to the same carbon atom or to two or more different carbon atoms.
Catalysts of the Disclosure
[0059] Provided herein are compounds having a structure represented by formula (I), or dimers thereof:
##STR00004##
[0060] The compound having a structure represented by formula (I-dimer) can also be represented as:
##STR00005##
[0061] In general, in the compounds of the disclosure, each M is a transition metal. In embodiments, M is a group 6 transition metal. In embodiments, M is molybdenum (Mo) or tungsten (W). In embodiments, M is tungsten (W).
[0062] Throughout the disclosure, each metal-nitrogen bond is generally represented as a double bond. However, it will be understood that the metal-nitrogen bond can also have some triple bond character due to additional overlapping pi bonds. Thus, as used herein, in the structure of Formula (I) or dimers thereof, metal-nitrogen triple bonds (MN) are considered equivalent to metal-nitrogen double bonds (MN).
[0063] In general, R.sup.2 is selected from the group of H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, OAr.sup.1, O(C.sub.1-C.sub.20alkyl), and OH. In embodiments, R.sup.2 is H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, or C.sub.1-C.sub.20haloalkyl. In embodiments, R.sup.2 is H, C.sub.1-C.sub.20haloalkyl or C.sub.1-C.sub.20alkyl. In embodiments, R.sup.2 is tert-butyl.
[0064] In general, each occurrence of R.sup.3 is independently selected from the group of H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, OAr.sup.1, O(C.sub.1-C.sub.20alkyl), and OH, or R.sup.3 together with an adjacent R.sup.4 and the carbon atoms to which they are attached form a five- to eight-membered cyclic group. In embodiments, each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, and OH. In embodiments, each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20haloalkyl or C.sub.1-C.sub.20alkyl. In embodiments, at least one R.sup.3 is tert-butyl. In embodiments, each R.sup.3 is tert-butyl.
[0065] In general, each occurrence of R.sup.4 is independently selected from the group of Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.2, N(C.sub.1-C.sub.20alkyl).sub.2, NH(C.sub.1-C.sub.20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, halo, and OH, or two adjacent R.sup.4, together with the carbon atoms to which they are attached, can form a five- to eight-membered cyclic group. In embodiments, each R.sup.4 is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, Ar.sup.1, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, halo, C.sub.1-C.sub.20haloalkyl, and OH. In embodiments, each R.sup.4 C.sub.1-C.sub.20alkyl, Ar.sup.1, C.sub.5-C.sub.8cycloalkyl, or C.sub.1-C.sub.20haloalkyl.
[0066] In general, m can be 0, 1, 2, or 3. In embodiments, each m is 0. In embodiments, at least one m is 1. In embodiments, at least one m is 2. In embodiments, at least two m are 1.
[0067] In general, each L is independently absent or can be an L-type ligand. In embodiments, each L is independent absent or can be selected from the group of phosphine, phosphite, phosphonite, phosphinite, amine, amide, imine, alkoxy, ether, thioether, and a five- or six-membered monocyclic group having 1 to 3 ring heteroatoms; or both L together comprise a bidentate ligand. L-type ligands are described in detail throughout Gray L. Spessard and Gray O. Miessler, Organometallic Chemistry, published by Oxford University Press, 2010, for example, on page 59, which is herein incorporated by reference. Suitable bidentate ligands include, but are not limited to, bipyridine, ethylenediamine, diaminocyclohexane, acetylacetonate, oxalate, and phenanthroline. The five- or six-membered monocyclic groups can include 1 to 3 heteroatoms or 1 to 2 heteroatoms, for example, pyridine, pyridazine, pyrimidine, pyrazine, triazine, pyrrole, pyrazole, imidazoletriazole, pyran, pyrone, dioxin, and furan. The five- or six-membered monocyclic groups can be substituted with halo, C.sub.1-C.sub.22alkyl, substituted C.sub.1-C.sub.22alkyl, C.sub.1-C.sub.22heteroalkyl, substituted C.sub.1-C.sub.22heteroalkyl, C.sub.6-C.sub.24aryl, substituted C.sub.6-C.sub.24 aryl, C.sub.6-C.sub.24heteroaryl, substituted C.sub.6-C.sub.24 heteroaryl, and functional groups, including but not limited to, C.sub.1-C.sub.22 alkoxy, C.sub.6-C.sub.24 aryloxy, C.sub.2-C.sub.22 alkylcarbonyl, C.sub.6-C.sub.24 arylcarbonyl, carboxy, carboxylate, carbamoyl, carbamido, formyl, thioformyl, amino, nitro, and nitroso.
[0068] In embodiments, L is absent or selected from the group of NH.sub.3, N(R.sup.5).sub.3, Ar.sup.1, C.sub.1-6hydroxyalkyl, NCR.sup.5, NC(R.sup.5).sub.2, OR.sup.5, O(R.sup.5).sub.2, P(R.sup.5).sub.3, P(OR.sup.5).sub.3, PR.sup.5(OR.sup.5).sub.2, PR.sup.5.sub.2(OR.sup.5), R.sup.5(CO)N(R.sup.5).sub.2, R.sup.5(CO)NHR.sup.5, R.sup.5CHO, R.sup.5COR.sup.5, R.sup.5COOR.sup.5, SR.sup.5, and S(R.sup.5).sub.2. In embodiments, L is Ar.sup.1, N(R.sup.5).sub.3, P(R.sup.5).sub.3, S(R.sup.5).sub.2 or O(R.sup.5).sub.2. In embodiments, L is tetrahydrofuran (THF), pyridine, or thiophene.
[0069] In general, R.sup.1 is independently selected from the group of H, NNR.sup.a, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, Si(CH.sub.3).sub.3, and Ar.sup.1. In embodiments, R.sup.1 is H, phenyl, Si(CH.sub.3).sub.3, n-octyl, cyclohexyl, or benzyl. In embodiments, R.sup.1 is NNR.sup.a.
[0070] In general, R.sup.a is independently selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-20haloalkyl, and Ar.sup.1. In embodiments, R.sup.a is C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, or Ar.sup.1. In embodiments, R.sup.a is phenyl, benzyl, n-octyl, or cyclohexyl.
[0071] In general, each occurrence of R.sup.5 is independently selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, and Ar.sup.1, or two R.sup.5, together with the atoms to which they are attached, form a five- to eight-membered heterocycle comprising from 1 to 3 ring heteroatoms selected from O, N, and S. In embodiments, each R.sup.5 of L is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, and Ar.sup.1.
[0072] In general, each occurrence of Ar.sup.1 is independently selected from C.sub.6-C.sub.20aryl, C.sub.1-C.sub.3alkylene-C.sub.6-C.sub.20aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S. In embodiments, each Ar.sup.1 is C.sub.6-C.sub.20aryl, or C.sub.1-C.sub.3alkylene-C.sub.6-C.sub.20aryl. In embodiments, each Ar.sup.1 of R.sup.3 is C.sub.6-20aryl or C.sub.1-3alkylene-C.sub.6-20aryl. In embodiments, each Ar.sup.1 of R.sup.4 is C.sub.6-20aryl or C.sub.1-3alkylene-C.sub.6-20aryl. In embodiments, each Ar.sup.1 of R.sup.5 is C.sub.6-20aryl or C.sub.1-3alkylene-C.sub.6-20aryl. In embodiments, each Ar.sup.1 of R.sup.1 is C.sub.0-3alkylene-C.sub.6-20aryl.
Methods of Making the Catalysts of the Disclosure
[0073] Further provided herein are methods for making the compound having a structure represented by formula (I) or dimers thereof, comprising reacting a compound of formula (II) and an organoazide having a structure of formula (III):
##STR00006##
[0074] In general, L is as described above. In embodiments, at least one L is absent. In embodiments wherein L is absent, the compound of formula (II) is coordinatively unsaturated. In embodiments, at least one L is a phosphine. In embodiments, at least one L is an amine. In refinements of the foregoing embodiments, at least one L is selected from NH.sub.2, dimethyl amine and diethyl amine. In embodiments, at least one L is an ether. In embodiments at least one L is a five- or six-membered monocyclic group having 1 to 3 ring heteroatoms. In refinements of the foregoing embodiment, at least one L is selected from tetrahydrofuran, tetrahydrothiophene, pyridine, and tetrahydropyran. In some embodiments, both L together comprise a bidentate ligand selected from bipyridine, ethylenediammine, diaminocyclohexane, acetylacetonate, oxalate, and phenanthroline.
[0075] In embodiments, L can comprise THF and derivatives thereof, thiophene and derivatives thereof, or pyridine and derivatives thereof. In embodiments, both L's are present and each L is THF.
[0076] In general, each occurrence of R can comprise H, C.sub.1-20alkyl, C.sub.3-8cycloalkyl, Si(R.sup.5).sub.3, or Ar.sup.1.
[0077] In general, each occurrence of R.sup.2 can comprise H, Ar.sup.1, C.sub.1-20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-20haloalkyl, NH.sub.2, N(C.sub.1-22 alkyl).sub.2, NH(C.sub.1-22 alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, OAr.sup.1, O(C.sub.1-22 alkyl), or OH. In embodiments, R.sup.2 is H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, or C.sub.1-C.sub.20haloalkyl. In embodiments, R.sup.2 is H, C.sub.1-C.sub.20haloalkyl or C.sub.1-C.sub.20alkyl. In embodiments, R.sup.2 is tert-butyl.
[0078] In general, each occurrence of R.sup.3 can comprise H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-20alkyl, NH.sub.2, N(C.sub.1-20alkyl).sub.2, NH(C.sub.1-20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, OAr.sup.1, O(C.sub.1-20alkyl), OH, or R.sup.3 together with an adjacent R.sup.4 and the carbon atoms to which they are attached form a five- to eight-membered cyclic group. In embodiments, each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, halo, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, and OH. In embodiments, each R.sup.3 is independently selected from H, Ar.sup.1, C.sub.1-C.sub.20haloalkyl or C.sub.1-C.sub.20alkyl. In embodiments, at least one R.sup.3 is tert-butyl. In embodiments, R.sup.3 is tert-butyl.
[0079] In general, each occurrence of R.sup.4 can comprise Ar.sup.1, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, C.sub.1-C.sub.20haloalkyl, COOH, COOC.sub.1-20alkyl, NH.sub.2, N(C.sub.1-20alkyl).sub.2, NH(C.sub.1-20alkyl), NHAr.sup.1, N(Ar.sup.1)(C.sub.1-20alkyl), N(Ar.sup.1).sub.2, SH, halo, OH, or two adjacent R.sup.4, together with the carbon atoms to which they are attached, can form a five- to eight-membered cyclic group. In embodiments, each R.sup.4 is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, Ar.sup.1, COOH, COOC.sub.1-C.sub.20alkyl, NH.sub.3, SH, halo, C.sub.1-C.sub.20haloalkyl, and OH. In embodiments, each R.sup.4 is C.sub.1-C.sub.20alkyl, Ar.sup.1, C.sub.5-C.sub.8 cycloalkyl, or C.sub.1-C.sub.20haloalkyl.
[0080] In general, each occurrence of Ar.sup.1 can comprise C.sub.6-20aryl, C.sub.1-3alkylene-C.sub.6-20aryl, or a 5-12 membered heteroaryl comprising from 1 to 3 ring heteroatoms selected from O, N, and S.
[0081] In general, m can be 0, 1, 2, or 3. In embodiments, each m is 0. In embodiments, at least one m is 1. In embodiments, at least one m is 2. In embodiments, at least two m are 1.
[0082] In general, each occurrence of R.sup.5 is independently selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, and Ar.sup.1, or two R.sup.5, together with the atoms to which they are attached, form a five- to eight-membered heterocycle comprising from 1 to 3 ring heteroatoms selected from O, N, and S. In embodiments, each R.sup.5 of L is independently selected from C.sub.1-C.sub.20alkyl, C.sub.5-C.sub.8cycloalkyl, and Ar.sup.1.
[0083] In embodiments, the reaction of the compound of formula (II) and the compound of formula (III) can occur neat, for example, in cases when the compound of formula (II) is a liquid. In embodiments, the reaction of the compound of formula (II) and the compound of formula (III) can occur in solution. Suitable solvents include nonpolar aprotic solvents, such as, but not limited to, benzene, toluene, hexanes, pentanes, dichloromethane, trichloromethane, chloro-substituted benzenes, deuterated analogs of the foregoing and combinations of any of the foregoing. As will be understood by one of ordinary skill in the art, polar aprotic solvents may also be suitable provided they do not compete with the organoazide of formula (III) to coordinate at the metal center. Suitable polar aprotic solvents can include, but are not limited to, diethyl ether, ethyl acetate, acetone, dimethylformamide, dimethoxyethane, tetrahydrofuran, acetonitrile, dimethyl sulfoxide, nitromethane, propylene carbonate, deuterated analogs of the foregoing, and combinations of the foregoing.
[0084] The reaction of the compound of formula (II) and the compound of formula (III) can occur at any suitable temperature for any suitable time. It is well understood in the art that the rate of a reaction can be controlled by tuning the temperature. Thus, in general, as the reaction temperature increases the reaction time can decrease.
[0085] Reaction temperatures can be in a range of about 80 C. to about 100 C., about 70 to about 80 C., about 50 C. to about 75 C., about 25 C. to about 50 C., about 0 C. to about 35 C., about 5 C. to about 30 C., about 10 C. to about 25 C., about 15 C. to about 25 C., or about 20 C. to about 25 C., for example, about 0 C., about 5 C., about 10 C., about 15 C., about 20 C., about 25 C., about 30 C., or about 35 C. Reaction times can be instantaneous or in a range of about 30 seconds to about 72 h, about 1 min to about 72 h, about 5 min to about 72 h, about 10 min to about 48 h, about 15 min to about 24 h, about 20 min to about 12 h, about 25 min to about 6 h, or about 30 min to about 3 h, for example, 30 seconds, 1 min, 5 min, 10 min, 15 min, 20 min, 25 min, 30 min, 35 min, 40 min, 45 min, 50 min, 55 min, 60 min, 75 min, 90 min, 105 min, 2 h, 3 h, 4 h, 5 h, 6 h, 12 h, 18 h, 24 h, 36 h, 48 h, 60 h, or 72 h.
[0086] In embodiments, reaction of the compound of formula (II) and the compound of formula (III) can be done under conditions sufficient to drive off nitrogen and prepare a compound of formula (I), wherein R.sup.1 is selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, and Ar.sup.1.
[0087] In alternative embodiments, the reaction of the compound of formula (II) and the compound of formula (III) can be done under conditions sufficient to prepare a compound of formula (I), wherein R.sup.1 is NNR.sup.a. Such a compound of formula (I) can have a structure according to formula (I):
##STR00007##
wherein each of R.sup.a, R.sup.2, R.sup.3, R.sup.4, and m are defined as defined herein for compounds of formula (I). It will be understood that compounds of formula (I) are a subset of compounds of formula (I), wherein R.sup.1 is NNR.sup.a. In embodiments, the methods of the disclosure further provide converting a compound of formula (I) to a compound of formula (I), wherein R.sup.1 selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, Si(R.sup.5).sub.3, and Ar.sup.1.
[0088] The conditions sufficient to prepare a compound of formula (I) directly from a compound of formula (I) wherein R.sup.1 is selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, Si(R.sup.5).sub.3, and Ar.sup.1 from the compound of formula (II) and organoazide having a structure of formula (III) are the same conditions sufficient to convert a compound of formula (I) to a compound of formula (I) wherein R.sup.1 is selected from the group of H, C.sub.1-C.sub.20alkyl, C.sub.3-8cycloalkyl, C.sub.1-C.sub.20haloalkyl, Si(R.sup.5).sub.3, and Ar.sup.1, for example, by heating the mixture of compound (III) and compound (II) or heating compound (I). Heating can take place in a solvent at a temperature of about 50 C., about 60 C., about 70 C., about 80 C., about 90 C., or about 100 C. Suitable solvents include any solvent disclosed herein as suitable for the reaction of the compound of formula (II) with the organoazide of formula (III).
Methods of Preparing Polymers
[0089] The disclosure further provides a method of preparing a cyclic polymer, the method comprising admixing a plurality of alkene monomers, alkyne monomers, or both, in the presence of the catalyst of formula (I) or dimer thereof, herein under conditions sufficient to polymerize the plurality of alkene monomers, alkyne monomers, or both thereby forming the cyclic polymer, wherein the cyclic polymer ring comprises alkene groups.
[0090] Cyclic polymers can be prepared from any alkene monomer, i.e. any compound that includes a carbon-carbon double bond. In embodiments, more than one alkene monomer can be defined as the plurality of alkene monomers. A wide variety of alkene monomers, including, but not limited to, unsubstituted, monosubstituted, or disubstituted alkenes can be used to prepare cyclic polymers. Substituted alkenes can include alkenes substituted with 1 to 3 heteroatoms selected from oxygen, nitrogen, and sulfur. The alkene monomer can be a cyclic alkene. In embodiments, the cyclic alkene monomer can be bicyclic. In embodiments, the plurality of alkenes can comprise a mixture of different alkene monomers. In embodiments, the plurality of alkene monomers can comprise the same alkene monomers. The plurality of alkenes polymerized to form a cyclic polymer can comprise unsubstituted or substituted cyclopropene, cyclobutene, cyclopentene, cycloheptene, and cyclooctene, norbornene, dicyclopentadiene, norbornene anhydride, diester from norbornene anhydride, imide from norbornene anhydride, oxanorbornene, oxanorbornene anhydride, ester of oxanorbornene anhydride, and imide of oxanorbornene anhydride, or combinations thereof, wherein the ester is from a C.sub.1-C.sub.10 alkyl or aryl alcohol, the imide is from C.sub.1-C.sub.10 alkyl or aryl amine; wherein substituents can be C.sub.1-C.sub.10 alkyl, aryl, C.sub.1-C.sub.10 alkoxy, aryloxy, C.sub.1-C.sub.10 carboxylic acid ester, or carboxylic acid amide, optionally substituted one or two times with C.sub.1-C.sub.10 alkyl or aryl.
[0091] Cyclic polymers can be prepared from any alkyne monomer, i.e. any compound that includes a carbon-carbon triple bond. In embodiments, more than one alkyne monomer can be defined as the plurality of alkyne monomers. In embodiments, the alkyne monomer is selected from cyclooctyne, cycloocta-1,5-diyne, phenylacetylene, and
##STR00008##
[0092] Examples of solvents that may be used in the polymerization reaction include organic, protic, or aqueous solvents that are inert under the polymerization conditions, such as aromatic hydrocarbons, halogenated hydrocarbons, ethers, aliphatic hydrocarbons, alcohols, water, or mixtures thereof. Suitable halogenated hydrocarbon solvents include methylene chloride, chloroform, chlorobenzene, 1,2-dichloroethane, dichlorobenzene, and mixtures thereof.
[0093] The polymerization can be carried out at, for example, ambient temperatures at dry conditions under an inert atmosphere. The polymerization can be carried out at a temperature in the range of about 0 C. to about 100 C. or greater, for example, in a range of about 10 C. to about 60 C. or about 20 C. to about 40 C. Polymerization times will vary, depending on the particular monomer, metallacyclopropene compound, and desired molecular weight of the cyclic polymer product. The progress of the reaction can be monitored by standard techniques, e.g., nuclear magnetic resonance (NMR) spectroscopy.
[0094] The molecular weight of the cyclic polymers can be small, equivalent to oligomers of three to ten repeating units, or the molecular weights can be of any size up to tens and hundreds of thousands or millions in molecular weight, for example, in a range of about 200 Da to about 5,000,000 Da, about 500 Da to about 4,000,000 Da, about 1,000 Da to about 3,000,000 Da, about 5,000 Da to about 2,000,000 Da or about 10,000 to about 1,000,000 Da. The cyclic polyalkene can be converted to substituted cyclic polyalkanes by an addition reaction at the alkene groups of the cyclic polyalkenes; for example, the addition of halogens, alcohols, amines, or any other olefin addition reactions.
[0095] The cyclic polymers can display one or more geometries across the polymer backbone. Tacticity can be determined with .sup.1H and .sup.13C{.sup.1H} NMR spectroscopy at low conversion and post-polymerization modification of the cyclic polymer. Generally, the cyclic polymers are syndiotactic. In embodiments, the cyclic polymer is syndiotactic. In embodiments, the alkene groups of the cyclic polymer are at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% cis. In embodiments, the cyclic polymer is syndiotactic and at least 90% of the alkene groups are cis.
[0096] Following polymer synthesis and recovery, the unsaturated polymer provided may be hydrogenated using conventional means, e.g., via standard H.sub.2/Pd/C procedures or via tosyl-hydrazine decomposition. Generally, either procedure will result in a saturated polymer having hydrogenated more than 99% of the unsaturated functionalities in the polymer backbone, as may be determined by .sup.1H and .sup.13C{.sup.1H} NMR spectroscopy. In embodiments, the method herein can further comprise hydrogenating the cyclic polymer alkene groups to form cyclic polymer alkane groups. In embodiments, the hydrogenation is performed under conditions sufficient to fully hydrogenate the cyclic polymer alkene groups, thereby forming a saturated cyclic polymer. As used herein, a cyclic polymer is fully hydrogenated if more than 99% of the unsaturated functionalities are hydrogenated. Advantageously, the stereoregularity of the polymers are maintained during hydrogenation, providing for stereoregular saturated cyclic polymers.
EXAMPLES
Materials and Methods
[0097] Unless specified otherwise, all manipulations were performed under an inert atmosphere using glove-box techniques. Toluene and pentane were dried using a GlassCountour drying column and stored over 3 molecular sieves. Benzene-d.sub.6 (Cambridge Isotopes) was dried over calcium hydride (CaH.sub.2), distilled, and stored over 3 molecular sieves. [.sup.tBuOCO]WC.sup.tBu(THF).sub.2 (Complex A) was prepared according to literature procedure (Sarkar, S. et al., J. Am. Chem. Soc. 2012, 134, 4509-4512). Linear cis-syndiotactic polynorbornene (cis-poly(NBE)) was synthesized following a literature procedure (Grubbs et al., J. Am. Chem. Soc. 2016, 138, 1394-1405), using the commercially available catalyst, complex 15 having a structure of
##STR00009##
(Grubbs et al., J. Am. Chem. Soc. 2013, 135, 10032-10035). Complex B was purchased from Sigma-Aldrich (CAS 1352916-84-7, Hoveyda-Grubbs Catalyst M2001) and used without further purification. Post polymerization bromination of poly(NBE) was conducted according to literature procedure (Hyvl et al., Macromolecules 2015, 48, 3148-3152). NMR spectra were obtained on Varian INOVA 500 MHz and Varian INOVA2 500 MHz spectrometers, or equivalent. Chemical shifts are reported in (ppm). For .sup.1H and .sup.13C{.sup.1H}NMR spectra, the residual solvent peaks were used as an internal reference. Molecular weight, radius of gyration and polydispersity were determined by size exclusion chromatography (SEC) in dimethylacetamide (DMAc) with 50 mM LiCl at 50 C. and a flow rate of 1.0 mL/min (Agilent isocratic pump, degasser, and auto-sampler, columns: PLgel 5 m guard+two ViscoGel I-series G3078 mixed bed columns: molecular weight range 0-2010.sup.3+ and 0-10010.sup.4 g mol.sup.1). Detection consisted of a Wyatt Optilab T-rEX refractive index detector, or equivalent, operating at 658 nm and a Wyatt miniDAWN Treos light scattering detector, or equivalent, operating at 659 nm. Absolute molecular weights and polydispersities were calculated using Wyatt ASTRA software or equivalent.
Example 1: Synthesis of Catalyst 1
General Procedure
[0098] In a vial equipped with a magnetic stir bar, Complex A, [.sup.tBuOCO]W=C.sup.tBu(THF).sub.2 (0.13 mmol) was dissolved in 5 mL of benzene. An aliquot of the appropriate azide, N.sub.3R (0.14 mmol) was added at room temperature. In these preparations, R was one of phenyl, benzyl, n-octyl, or cyclohexyl. After the appropriate reaction time, the solution was dried under vacuum yielding catalyst 1-R.
##STR00010##
TABLE-US-00001 R group Reaction Time Solvent; (Volume) 1-Ph Phenyl 15 minutes Benzene; (5 mL) 1-Bn Benzyl 15 minutes Benzene; (5 mL) 1-Oct n-Octyl 15 minutes Benzene; (5 mL) 1-Cy Cyclohexyl 15 minutes Benzene; (5 mL)
Synthesis and Characterization of 1-Ph
[0099] In a vial equipped with a stir bar, complex A (100 mg, 0.13 mmol) was dissolved in 5 mL of benzene, phenyl azide (16.7 mg, 15.4 L, 0.14 mmol) was added in the above solution at room temperature. An immediate color change from dark red to yellowish orange was observed. The reaction was then stirred at room temperature for 15 minutes. Volatiles were removed under vacuum yielding catalyst 1-Ph.
[0100] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.90 (m, 2H, ArH.sub.36,40), 7.42 (d, 2H, J=8 Hz, ArH.sub.8,10), 7.36 (dd, 2H, J.sub.1=4 Hz, J.sub.2=8 Hz, ArH.sub.3,16), 7.32 (dd, 2H, J.sub.1=4 Hz, J.sub.2=8 Hz, ArH.sub.5,14), 7.21 (t, 1H, J=8 Hz, ArH.sub.9), 7.08 (m, 2H, ArH.sub.37,39), 7.03 (m, 1H, ArH.sub.38), 6.86 (dd, 2H, J.sub.1=J.sub.2=8 Hz, ArH.sub.4,15), 3.58 (m, 4H, THFH.sub.32,35), 1.58 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.05 (m, 4H, THFH.sub.33,34), 0.96 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0101] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 274.94 (s, WC.sub., C.sub.27), 169.36 (s, C.sub.1,18), 152.14 (s, C.sub.7,11), 150.61 (s, C.sub.41), 138.84 (s, C.sub.2,17), 133.37 (s, C.sub.9), 131.38 (s, C.sub.6,13), 129.58 (s, C.sub.38), 129.54 (s, C.sub.37,39), 128.68 (s, C.sub.5,14), 126.67 (s, C.sub.3,16), 123.00 (s, C.sub.12), 122.26 (s, C.sub.36,40), 119.72 (s, C.sub.4,15), 71.98 (s, C.sub.32,35), 47.41 (s, C.sub.28), 35.51 (s, C.sub.19,23), 34.40 (s, C.sub.29-31), 30.68 (s, C.sub.20-22, 24-26), 25.24 (s, C.sub.33,34). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00011##
Characterization of 1-Bn
[0102] In a vial equipped with a stir bar, complex A (100.0 mg, 0.13 mmol) was dissolved in 5 mL of benzene, then benzyl azide (18.6 mg, 17.5 L, 0.14 mmol) was added at room temperature. An immediate color change from dark red to light yellow was observed. The resultant solution was then stirred at room temperature for 15 min. All volatiles were removed under vacuum yielding 1-Bn.
[0103] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.42 (d, 2H, J=7.7 Hz, ArH.sub.8,10), 7.39 (dd, 2H, J.sub.1=1.8 Hz, J.sub.2=7.9 Hz, ArH.sub.3,16), 7.33 (dd, 2H, J.sub.1=1.8 Hz, J.sub.2=7.9 Hz, ArH.sub.5,14), 7.29 (m, 2H, ArH.sub.38,42), 7.22 (t, 1H, J=7.7 Hz, ArH.sub.9), 7.16 (m, 2H, ArH.sub.39,41), 7.06 (m, 1H, ArH.sub.40), 6.87 (t, 2H, J=7.9 Hz, ArH.sub.4,16), 4.82 (s, 2H, Bz-H.sub.36), 3.56 (m, 4H, THFH.sub.32,35), 1.59 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.23 (m, 4H, THFH.sub.33,34), 0.90 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0104] .sup.13C{.sup.1H}NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 274.25 (s, WC), 169.25 (s, C.sub.1,18), 151.56 (s, C.sub.7,11), 138.79 (s, C.sub.2,17), 136.71 (s, C.sub.37), 133.01 (s, C.sub.9), 131.54 (s, C.sub.6,13), 129.49 (s, C.sub.8,10), 129.36 (s, C.sub.5,14), 128.71 (s, C.sub.39,41), 128.65 (s, C.sub.40), 127.76 (s, C.sub.38,42), 127.52 (s, C.sub.12), 126.63 (s, C.sub.3,16), 119.66 (s, C.sub.4,15), 71.90 (s, C.sub.32,35), 66.86 (s, C.sub.36), 47.38 (s, C.sub.28), 35.52 (s, C.sub.19,23), 34.35 (s, C.sub.29-31), 30.76 (s, C.sub.20-22,24-26), 25.24 (s, C.sub.33,34). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00012##
Characterization of 1-Oct
[0105] In a vial equipped with a stir bar, complex A (200.0 mg, 0.26 mmol) was dissolved in 5 mL of benzene, then n-octyl azide (43.46 mg, 48.30 L, 0.28 mmol) was added at room temperature. An immediate color change from dark red to light red was observed. The reaction was then stirred at room temperature for 15 min. All, volatiles were removed under vacuum yielding 1-Oct.
[0106] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.42 (d, 2H, J=8 Hz, ArH.sub.8,10), 7.37 (dd, 2H, J.sub.1=2 Hz, J.sub.2=8 Hz, ArH.sub.3,16), 7.31 (dd, 2H, J.sub.1=2 Hz, J.sub.2=8 Hz, ArH.sub.5,14), 7.24 (t, 1H, J=8 Hz, ArH.sub.9), 6.85 (t, 2H, J=8 Hz, ArH.sub.4,15), 3.72 (t, J=7 Hz, H.sub.36), 3.57 (m, 4H, THFH.sub.32,35), 1.75 (m, 2H, H.sub.37), 1.63 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.33 (m, 2H, H.sub.38), 1.25 (m, 4H, THFH.sub.33,34), 1.23 (m, 8H, H.sub.38-42), 0.90 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31), 0.89 (m, 3H, H.sub.43). The number labels in the structure below correspond to the number labels for each resonance reported.
[0107] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 273.86 (s, WC.sub., C.sub.27), 169.31 (s, C.sub.1,18), 151.49 (s, C.sub.7,11), 138.76 (s, C.sub.2,17), 132.95 (s, C.sub.9), 131.59 (s, C.sub.6,13), 129.47 (s, C.sub.8,10), 128.71 (s, C.sub.5,14), 126.58 (s, C.sub.3,16), 124.13 (s, C.sub.12), 119.57 (s, C.sub.4,15), 69.94 (s, C.sub.32,35), 62.63 (s, C.sub.36), 47.25 (s, C.sub.28), 35.55 (s, C.sub.19,23), 34.30 (s, C.sub.29-31), 32.16 (s, C.sub.41), 30.83 (s, C.sub.20-22,24-26), 29.73 (s, C.sub.40), 29.62 (s, C.sub.39), 28.69 (s, C.sub.37), 27.70 (s, C.sub.38), 25.50 (s, C.sub.33,34), 23.03 (s, C.sub.42), 14.33 (s, C.sub.43). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00013##
Characterization of 1-Cy
[0108] In a vial equipped with a magnetic stir bar, complex A (100.0 mg, 0.13 mmol) was dissolved in 5 mL of benzene, then cyclohexyl azide (17.5 mg, 19.4 L, 0.14 mmol) was added at room temperature. An immediate color change from dark red to light yellow was observed. The reaction was then stirred at room temperature for 15 min. All volatiles were removed under vacuum yielding 1-Cy.
[0109] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.43 (d, 4H, J=7.6 Hz, ArH.sub.8,10,8,10), 7.40 (dd, 4H, J.sub.1=1.8 Hz, J.sub.2=7.9 Hz, ArH.sub.3,16,3,16), 7.33 (dd, 4H, J.sub.1=1.8 Hz, J.sub.2=7.9 Hz, ArH.sub.5,14,5,14), 7.22 (t, 2H, J=7.6 Hz, ArH.sub.9,9), 6.87 (t, 4H, J=7.9 Hz, ArH.sub.4,15,4,15), 3.63 (m, 2H, H.sub.32,32), 1.87 (m, 2H, Cy-H(eq.).sub.33,37,33,37), 1.77 (m, 2H, Cy-H(ax.).sub.33,37,33,37), 1.65 (s, 38H, H.sub.20-22,24-26,20-22,24-26), 1.43 (m, 2H, Cy-H(ax.,eq.).sub.35,35), 1.16 (m, 8H, Cy-H(ax.,eq.).sub.34,36,34,36), 0.93 (s, 18H, WCC(CH.sub.3).sub.3, H.sub.29-31,29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0110] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 273.57 (s, WC.sub., C.sub.27,27), 169.42 (s, C.sub.1,18,1,18), 151.63 (s, C.sub.7,11,7,11), 138.85 (s, C.sub.2,17,2,17), 131.60 (s, C.sub.6,13,6,13), 129.40 (s, C.sub.8,10,8,10), 128.72 (s, C.sub.5,14,5,14), 126.60 (s, C.sub.3,16,3,16), 124.07 (s, C.sub.12,12), 119.51 (s, C.sub.4,15,4,15), 69.80 (s, C.sub.32,32), 47.30 (s, C.sub.28,28), 35.58 (s, C.sub.19,23,19,23), 34.30 (s, C.sub.29-31,29-31), 31.68 (s, C.sub.33,37,33,37), 30.83 (s, C.sub.20-22,24-26,20-22,24-26), 25.86 (s, C.sub.35,35), 24.44 (s, C.sub.34,36,34,36). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00014##
Example 2: Synthesis of Catalyst 2
General Procedure
[0111] In a vial equipped with a magnetic stir bar, Complex A, [.sup.tBuOCO]WC.sup.tBu(THF).sub.2 (0.13 mmol) was dissolved in 5 mL of benzene. An aliquot of the appropriate azide, N.sub.3R (0.14 mmol) was added at room temperature. The resultant solution was then transferred in a Schlenk tube equipped with a magnetic stir bar and heated. After the appropriate reaction time, the solution was dried under vacuum yielding catalyst 2-R.
TABLE-US-00002 R of Azide Reaction R group (RN.sub.3) Time Reaction Conditions 2-Ph Phenyl Phenyl 2 days Benzene (6 mL); 80 C. 2-Bn Benzyl Benzyl 3 days Benzene (6 mL); 80 C. 2-TMS Trimethylsilyl Trimethylsilyl 2 days Benzene (5 mL); 80 C. 2-Cy Cyclohexyl Cyclohexyl 3 days Benzene (5 mL); 80 C. 2-H Hydrogen n-Octyl 1 day Benzene (1.5 mL); 80 C.
Synthesis and Characterization of 2-Ph
##STR00015##
[0112] Complex A (150 mg, 0.19 mmol) was dissolved in 6 mL of benzene in a vial equipped with a magnetic stir bar, phenyl azide (25.01 mg, 23.16 L, 0.21 mmol) was added in the above solution at room temperature. The resultant solution was then transferred in a Schlenk tube equipped with a magnetic stir bar and heated at 80 C. in oil bath for 2 days. Volatiles were removed under vacuum yielding 2-Ph.
[0113] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.46 (m, 2H, ArH.sub.36,40), 7.42 (d, 2H, J=6 Hz, ArH.sub.8,10), 7.36 (m, 4H, ArH.sub.3,5,14,16), 7.23 (t, 1H, J=6 Hz, ArH.sub.9), 7.17 (m, 2H, ArH.sub.37,39), 6.87 (m, 3H, ArH.sub.4,15,38), 3.68 (m, 4H, THFH.sub.32,35), 1.58 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.13 (m, 4H, THFH.sub.33,34), 0.90 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0114] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 272.44 (s, WC.sub., C.sub.27), 169.22 (s, C.sub.1,18), 156.76 (s, C.sub.41), 150.03 (s, C.sub.7,11), 138.88 (s, C.sub.2,17), 132.22 (s, C.sub.9), 132.03 (s, C.sub.6,13), 129.46 (s, C.sub.8,10), 128.85 (s, C.sub.37,39), 128.25 (s, C.sub.37,39), 126.57 (s, C.sub.12), 126.42 (s, C.sub.3,16), 124.05 (s, C.sub.38), 119.32 (s, C.sub.4,15), 72.25 (s, C.sub.32,35), 46.69 (s, C.sub.28), 35.44 (s, C.sub.19,23), 34.21 (s, C.sub.29,31), 30.84 (s, C.sub.20-22,24-26), 25.36 (s, C.sub.33,34). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00016##
Synthesis and Characterization of 2-Bn
[0115] In a vial equipped with a magnetic stir bar, complex A (100.0 mg, 0.13 mmol) was dissolved in 6 mL of benzene, then benzyl azide (18.64 mg, 17.5 L, 0.14 mmol) was added at room temperature. The resultant solution was then transferred to a Schlenk tube equipped with a magnetic stir bar and heated at 80 C. in oil bath for 3d, a color change from light orange to dark brown was observed. All volatiles were removed under vacuum yielding 2-Bn.
[0116] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.40 (m, 2H, ArH.sub.8,10), 7.39 (m, 2H, ArH.sub.3,16), 7.32 (dd, 2H, J.sub.1=1.8 Hz, J.sub.2=7.4 Hz, ArH.sub.5,14), 7.21 (m, 1H, ArH.sub.9), 7.21 (m, 2H, ArH.sub.39,41), 7.02 (m, 1H, ArH.sub.40), 6.88 (t, 2H, J=7.6 Hz, ArH.sub.4,16), 6.88 (m, 2H, ArH.sub.38,42), 5.42 (s, 2H, Bn-H.sub.36), 3.52 (m, 4H, THFH.sub.32,35), 1.65 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.09 (m, 4H, THFH.sub.33,34), 0.76 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0117] .sup.13C{.sup.1H}NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 270.96 (s, WC.sub.), 169.68 (s, C.sub.1,18), 150.86 (s, C.sub.7,11), 138.69 (s, C.sub.2,17), 132.08 (s, C.sub.6,13), 131.88 (s, C.sub.9), 129.36 (s, C.sub.40), 129.28 (s, C.sub.37), 128.92 (s, C.sub.8,10), 129.19 (s, C.sub.39,41), 128.85 (s, C.sub.5,14), 127.76 (s, C.sub.38,42), 126.37 (s, C.sub.12), 126.22 (s, C.sub.3,16), 118.88 (s, C.sub.4,15), 69.39 (s, C.sub.32,35), 66.52 (s, C.sub.36), 44.79 (s, C.sub.28), 35.44 (s, C.sub.19,23), 33.86 (s, C.sub.29-31), 30.64 (s, C.sub.20-22,24-26), 25.33 (s, C.sub.33,34). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00017##
Synthesis and Characterization of 2-Cy
##STR00018##
[0118] In a vial equipped with a magnetic stir bar, complex A (100.0 mg, 0.13 mmol) was dissolved in 6 mL of benzene, then cyclochexyl azide (17.5 mg, 19.4 L, 0.14 mmol) was added at room temperature. The resultant solution was then transferred to a Schlenk tube equipped with a magnetic stir bar and heated at 80 C. in oil bath for 3d, a color change from dark red to brown-yellow was observed. All volatiles were removed under vacuum yielding 2-Cy.
[0119] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.39 (m, 6H, ArH.sub.3,5,8,10,14,16), 7.22 (t, 1H, J=7.5 Hz, ArH.sub.9), 6.89 (2H, J=7.7 Hz, ArH.sub.4,15), 4.39 (m, 1H, Cy-H.sub.36), 3.64 (m, 4H, THFH.sub.32,35), 2.45 (d, 2H, J=10.3 Hz, Cy-H(eq.).sub.37,41), 1.70 (m, 2H, Cy-H(ax.).sub.37,41), 1.66 (s, 18H, H.sub.20-22,24-26), 1.50 (d, 2H, J=11.1 Hz, Cy-H(ax.,eq.).sub.39), 1.17 (m, 4H, Cy-H(ax.,eq.).sub.38,40), 1.16 (m, 4H, THFH.sub.33,34), 0.89 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0120] .sup.13C{.sup.1H}NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 269.66 (s, WC.sub.a, C.sub.27), 169.29 (s, C.sub.1,18), 148.45 (s, C.sub.7,11), 138.47 (s, C.sub.2,17), 132.56 (s, C.sub.6,13), 131.18 (s, C.sub.9), 129.33 (s, C.sub.8,10), 128.93 (s, C.sub.5,14), 128.53 (s, C.sub.3,16), 126.07 (s, C.sub.12), 118.92 (s, C.sub.4,15), 72.62 (s, C.sub.36), 71.36 (s, C.sub.32,35), 45.61 (s, C.sub.28), 36.85 (s, C.sub.37,41), 35.37 (s, C.sub.19,23), 34.27 (s, C.sub.29-31), 30.94 (s, C.sub.20-22,24-26), 30.60 (s, C.sub.33,34), 25.99 (s, C.sub.39), 25.43 (s, C.sub.38,40). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00019##
Synthesis and Characterization of 2-TMS
##STR00020##
[0121] Complex A (100 mg, 0.13 mmol) was dissolved in 5 mL of benzene in a vial equipped with a magnetic stir bar. An aliquot of trimethylsilyl azide (16.4 mg, 18.8 L, 0.14 mmol) was added at room temperature. The resultant solution was then transferred in a Schlenk tube equipped with a magnetic stir bar and heated at 80 C. in oil bath for 2 days, a color change from dark red to yellowish orange was observed. Volatiles were removed under vacuum yielding catalyst 2-TMS.
[0122] .sup.1H NMR (C.sub.6D.sub.6, 500 MHz) (ppm): 7.37 (m, 6H, ArH.sub.3,5,8,10,14,16), 7.19 (t, 1H, J=10 Hz, ArH.sub.9), 6.89 (dd, 2H, J.sub.1=J.sub.2=10 Hz, ArH.sub.4,15), 3.67 (m, 4H, THFH.sub.32,35), 1.62 (s, 18H, Ar-.sup.tBu, H.sub.20-22,24-26), 1.20 (m, 4H, THFH.sub.33,34), 0.92 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31), 0.37 (s, 9H, WN-TMS, H.sub.36-38). The number labels in the structure below correspond to the number labels for each resonance reported.
[0123] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 500 MHz) (ppm): 272.99 (s, WC.sub., C.sub.27), 168.56 (s, C.sub.1,18), 146.93 (s, C.sub.7,11), 138.42 (s, C.sub.2,17), 132.38 (s, C.sub.6,13), 128.84 (s, C.sub.5,14), 126.33 (s, C.sub.12), 126.11 (s, C.sub.3,16), 119.59 (s, C.sub.4,15), 72.00 (s, C.sub.32,35), 44.94 (s, C.sub.28), 35.51 (s, C.sub.19,23), 34.36 (s, C.sub.29-31), 31.26 (s, C.sub.20-22,24-26), 25.48 (s, C.sub.33,34), 3.45 (s, C.sub.36-38). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00021##
Synthesis and Characterization of 2-H
##STR00022##
[0124] Complex A (100 mg, 0.13 mmol) was dissolved in 1.5 mL of benzene-d.sub.6 in a vial, n-octyl azide (21.73 mg, 24.15 L, 0.14 mmol) was added in the above solution at room temperature. The resultant solution was then transferred to a sealable NMR tube and heated at 80 C. for 3d. A color change from dark red to light red was observed as the heating was continued. The reaction mixture was allowed to cool down and the volatiles were removed under vacuum yielding 2-H.
[0125] .sup.1H NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 7.60 (bs, 1H, WNH, H.sub.36), 7.38 (m, 4H, ArH.sub.3,8,10,16), 7.30 (dd, 2H, J.sub.1=1 Hz, J.sub.2=5 Hz, ArH.sub.5,14), 7.23 (t, 1H, J=5 Hz, ArH.sub.9), 6.84 (t, 2H, J=5 Hz, ArH.sub.4,15), 5.77 (m, 1H, H.sub.38), 5.00 (m, 2H, H.sub.37), 3.55 (m, 8H, THFH.sub.32,35), 1.98 (m, 2H, H.sub.39), 1.31 (m, 4H, H.sub.40,41), 1.26 (m, 4H, THFH.sub.33,34) 1.21 (m, 8H, H.sub.42,43), 0.87 (t, 3H, J=4 Hz, H.sub.44), 0.74 (s, 9H, WCC(CH.sub.3).sub.3, H.sub.29-31). The number labels in the structure below correspond to the number labels for each resonance reported.
[0126] .sup.13C{.sup.1H} NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 270.96 (s, WC.sub., C.sub.27), 169.72 (s, C.sub.1,18), 150.14 (s, C.sub.7,11), 139.26 (s, C.sub.38), 138.76 (s, C.sub.2,17), 132.14 (s, C.sub.6,9,13), 129.24 (s, C.sub.8,10), 128.89 (s, C.sub.5,14), 126.42 (s, C.sub.3,16), 126.16 (s, C.sub.12), 118.93 (s, C.sub.4,15), 114.52 (s, C.sub.37), 69.82 (s, C.sub.32,35), 44.83 (s, C.sub.28), 35.49 (s, C.sub.19,23), 34.23 (s, C.sub.39), 33.90 (s, C.sub.29-31), 32.11 (s, C.sub.42), 30.71 (s, C.sub.20-22,24-26), 29.31 (s, C.sub.40), 29.20 (s, C.sub.41), 25.58 (s, C.sub.33,34), 23.03 (s, C.sub.43), 14.35 (s, C.sub.44). The number labels in the structure below correspond to the number labels for each resonance reported.
[0127] .sup.15N NMR (C.sub.6D.sub.6, 400 MHz) (ppm): 337.51 (WNH, N.sub.36). The number labels in the structure below correspond to the number labels for each resonance reported.
##STR00023##
Example 3: Polymerization of Alkenes and Alkynes with Catalyst 1
General Procedure:
[0128] In a nitrogen atmosphere glove box, scintillation vials equipped with stir bars were charged with norbornene (100 mg, 1.06 mmol, 100 equiv) and toluene (0.1 M). To these solutions, the required amount of stock solution of catalyst 1-R (4 mg/mL) in toluene as prepared in example 1, was added in one portion with stirring. The vials were sealed and mixed. After the appropriate reaction time, the vials were removed from the glove box, unsealed and quenched with methanol. The polymers were collected via filtration and characterized with .sup.1H and .sup.13C NMR spectroscopy.
[0129] .sup.1H NMR of cis-syndiotactic polynorbornene (CDCl.sub.3, 400 MHz) (ppm): 5.21 (m, 2H, H.sub.1,6), 2.79 (m, 2H, H.sub.2,5), 1.90 (dt, 1H, J.sub.1=9.6 Hz, J.sub.2=5.48 Hz, H.sub.7), 1.80 (m, 2H, H.sub.3,4), 1.37 (m, 2H, H.sub.3,4), 1.01 (m, 1H, H.sub.7).
[0130] .sup.13C{.sup.1H}NMR of cis-syndiotactic polynorbornene (CDCl.sub.3, 400 MHz) (ppm): 134.85 (s, C.sub.1,6), 43.68 (s, C.sub.7), 39.58 (s, C.sub.2,5) 34.18 (s, C.sub.3,4).
##STR00024##
Polymerization with 1-Ph
[0131] Polynorbornene was synthesized using the general procedure outlined above with catalyst 1-Ph. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicate that the polymer was >99% cis- and >99% syndiotactic.
Polymerization with 1-Bn
[0132] Polynorbornene was synthesized using the general procedure outlined above with catalyst 1-Bn. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicate the polymer sample was cis-syndiotactic polynorbornene.
Polymerization with 1-Oct
[0133] Polynorbornene was synthesized using the general procedure outlined above with catalyst 1-Oct. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicate the polymer sample was cis-syndiotactic polynorbornene.
Polymerization with 1-Cy
##STR00025##
[0134] Polynorbornene was synthesized using the general procedure outlined above with catalyst 1-Cy. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicate the polymer sample was cis-syndiotactic polynorbornene.
[0135] Thus, example 3 demonstrates general preparation conditions for preparing a cyclic polymer according to the disclosure. The catalysts of the disclosure are further characterized in example 5.
Example 4: Polymerization of Alkenes and Alkynes with Catalyst 2
[0136] General Procedure: In a nitrogen atmosphere glove box, scintillation vials equipped with stir bars were charged with norbornene (100 mg, 1.06 mmol, 100 equiv) and toluene (0.1 M). To these solutions, the required amount of stock solution of catalyst 2-R (4 mg/mL) in toluene as prepared in Example 2, was added in one portion with stirring. The vials were sealed and mixed. After the appropriate reaction time, the vials were removed from the glove box, unsealed and quenched with methanol. The polymers were collected via filtration and characterized with .sup.1H and .sup.13C NMR spectroscopy.
##STR00026##
Polymerization with 2-Ph
[0137] Polynorbornene was synthesized using the general procedure outlined above with catalyst 2-Ph. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicated the polymer sample was cis-syndiotactic polynorbornene.
Polymerization with 2-Bn
[0138] Polynorbornene was synthesized using the general procedure outlined above with catalyst 2-Bn. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicated the polymer sample was cis-syndiotactic polynorbornene.
Polymerization with 2-TMS
[0139] Polynorbornene was synthesized using a modified procedure based on the procedure above with catalyst 2-TMS, rather than 2 h, the solution was stirred for 6 h at room temperature. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicated the polymer sample was cis-syndiotactic polynorbornene.
Polymerization with 2-H
[0140] Polynorbornene was synthesized using a modified procedure based on the procedure above with catalyst 2-H, rather than 2 h, the solution was stirred for 6 h at room temperature. The ratio of monomer:catalyst, yield, and percent cis-polynorbornene is provided in Table 1, below. .sup.1H and .sup.13C{.sup.1H} NMR spectra indicated the polymer sample was cis-syndiotactic polynorbornene.
TABLE-US-00003 TABLE 1 Reaction times and yields for the synthesis of cyclic polynorbornene with Catalyst 1, 1-R, and Catalyst 2, 2-R. Catalyst 1-R Catalyst 2-R Yield Yield [M/C] (%) % cis.sup.a [M/C] (%) % cis.sup.a 1-Ph 50:1 99 99 2-Ph 50:1 21 95 100:1 99 99 100:1 18 95 200:1 99 99 200:1 9 94 500:1 70 99 500:1 1000:1 37 99 1-Bn 50:1 99 98 2-Bn.sup.d 50:1 29 87 100:1 99 99 100:1 22 87 200:1 97 97 200:1 18 88 500:1 65 99 500:1 1000:1 20 97 1-Oct 50:1 99 99 2-H 50:1 36 90 100:1 99 99 100:1 32 88 200:1 95 99 200:1 25 89 500:1 79 99 500:1 10 89 1000:1 40 99 1000:1 1-Cy 50:1 85 99 2-TMS.sup.c 25:1 85 92 100:1 81 99 50:1 83 91 200:1 81 98 100:1 77 91 500:1 35 99 200:1 67 91 1000:1 27 97 [M/C] = [monomer/catalyst]. .sup.aDetermined by .sup.1H NMR spectroscopy. .sup.cReaction mixture was stirred for 6 h at room temperature. .sup.dThe catalyst solution contained about 15% impurity.
[0141] Catalysts 1-R produced cyclic polymers with yields of 20% or greater and 97% or greater cis stereochemistry. Catalysts 2-R produced cyclic polymer with yields of 9% or greater and 87% or greater cis stereochemistry. Additionally, the yield decreases as the M/C ratio increases for each of catalysts 1-R and 2-R. For 1-Bn, as the M/C ratio increased from 100:1 to 1000:1, the yield fell from 99% to 20%. For 2-H, the yield fell from 36% to 10%, as the M/C ratio increased from 50:1 to 500:1. Thus, example 4 demonstrates general preparation conditions for preparing a cyclic polymer according to the disclosure. The catalysts of the disclosure are further characterized in Examples 5 and 6.
Example 5Polymerization of Alkenes and Alkynes with Complex B [Ru(NHC(Ad)(Mes))(CH(PhO.SUP.i.Pr))-(.SUP.2.-NO.SUB.3.)]
[0142] Additionally, the polymerization of norbornene was investigated with commercially-available [Ru(NHC(Ad)(Mes))(CH(PhO.sup.iPr))-(.sup.2-NO.sub.3)] (complex B), following a literature procedure (Grubbs Et al., J. Am. Chem. Soc. 2016, 138, 1394-1405). The polymers formed from complex B, namely cis-selective (>95%) and syndiotactic (>95%) linear polynorbornene, were compared with the polymers formed using catalysts of the disclosure, cyclic polynorbornene from 1-R and 2-R.
TABLE-US-00004 TABLE 2 Catalysis conditions and characterization data for the synthesis of cyclic polynorbornene according to an embodiment of the disclosure. [M/C] M.sub.n.sup.b(kDa) .sup.b [M/C] M.sub.n.sup.b(kDa) .sup.b 1-Ph 50:1 83 1.99 50:1 301 3.70 100:1 156 2.42 2-Ph 100:1 362 3.45 200:1 118 1.80 200:1 287 3.28 500:1 303 1.67 500:1 1000:1 101 1.88 1-Bn 50:1 194 2.56 2-Bn.sup.d 50:1 317 1.92 100:1 213 2.17 100:1 384 2.07 200:1 263 1.73 200:1 513 1.52 500:1 237 1.89 500:1 1000:1 373 2.10 1-Oct 50:1 162 3.18 2-H 50:1 290 2.74 100:1 201 3.09 100:1 259 4.47 200:1 139 2.81 200:1 530 1.79 500:1 89 1.95 500:1 300 2.51 1000:1 137 2.43 1000:1 1-Cy 50:1 195 3.93 25:1 77 2.91 100:1 196 3.35 2-TMS.sup.c 50:1 128 3.90 200:1 194 3.02 100:1 90 2.65 500:1 207 2.85 200:1 85 3.79 1000:1 197 3.07 .sup.a[M/C] = [monomer/catalyst]. .sup.bDetermined by size exclusion chromatography and multi-angle light scattering. .sup.cReaction mixture was stirred for 6 h at room temperature. .sup.dThe catalyst solution contained about 15% impurity.
Activity and Stability of Catalysts 1-R and 2-R
[0143] The catalytic activity of catalyst 1-R was determined by quenching the reaction, as described above, after 3 min at room temperature with a monomer to catalyst ratio of 200:1. Catalysts 1-R were determined to have catalytic activities of approximately 1.0010.sup.5 g.sub.pmol.sup.1h.sup.1 (1-Ph), 8.1510.sup.4 g.sub.pmol.sup.1h.sup.1 (1-Oct), and 5.9310.sup.4 g.sub.pmol.sup.1h.sup.1(1-Bn). These activities exceed the activity of the previously reported tethered tungsten oxo, imido, and .sup.2-bound isocyanato complexes. Moreover, the 1-R catalysts are more stable than .sup.2-bound isocyanato complexes, which are the most active tethered tungsten catalysts known. (Gonsales, S. A. Et al., J. Am. Chem. Soc. 2016, 138 (15), 4996-4999; Jakhar, V. Et al. J. Am. Chem. Soc. 2021, 143 (2), 1235-1246; Slugovc, C. Et al. Organometallics 2005, 24 (10), 2255-2258; Bielawski, C. W. Et al. J. Am. Chem. Soc. 2003, 125 (28), 8424-8425)
[0144] The catalytic activity of the 1-R catalysts is not affected by light, which suggests that the azoimido ancillary ligand remains coordinated during polymerization and is supported by the absence of free azide in the IR spectra of polymerization reaction mixtures. Since norbornene can participate in [3+2] cycloaddition reactions with free organic azides, the effect of free azide on the polymerization rate and yield of catalyst 1-R was evaluated. (Wijnen, J. W. Et al., Tetrahedron Lett. 1995, 36, 5389-5392; Xie, S. Et, J. Am. Chem. Soc. 2015, 137, 2958-2966). An excess of azide was added to a 1:1 mixture of 1-Ph and norbornene, but excess azide did not have any noticeable effects on polymerization rate or yield, and produced no detectable cycloaddition product by .sup.1H NMR, suggesting the azoimdo catalyst 1-R remained intact during polymerization.
[0145] The molecular weights of polymers synthesized by azoimido catalysts 1-R are somewhat lower than the polymers synthesized by tungsten oxo and imido complexes but comparable to that of known tungsten alkylidyne complexes. (Sarkar, S. Et al., J. Am. Chem. Soc. 2012, 134, 4509-4512) While no trends for the catalysts 1-R can be readily found, it is believed the polymerization reaction produces a rapid change in viscosity during the reaction. (Jakhar, V. Et al., J. Am. Chem. Soc. 2021, 143, 1235-1246). The polymerization of norbornene exhibits slow initiation, rapid propagation, and results in formation of high molecular weight polymers that visibly alter the viscosity of the solution including precipitation of the polymer.
[0146] Additionally, initiator deactivation is believed to cause the low yields observed for imido 2-R catalysts. For example, as the M/C ratio increases, both the activity and stereoselectivity diminished for 2-Ph, producing 18% yield at a monomer/initiator ratio of 100:1 (Table 2). The low activity is in line with tungsten oxo complexes (60% yield after 7 h at room temperature). (Gonsales, S. A. Et al., J. Am. Chem. Soc. 2016, 138 (15), 4996-4999). Based on polymerization data obtained at room temperature after 3 min, the catalytic activity of 2-Ph was determined to be 487 g.sub.pmol.sup.1h.sup.1. Based on the data presented in Table 2, a similar trend can be observed for the other imido 2-R catalysts.
[0147] The polymerization of norbornene was evaluated in real time using catalysts 1-Ph and 2-Ph with a monomer/initiator ratio of 15:1, by collecting NMR spectra in real-time over the course of the polymerization reaction and these results are shown in
[0148] Polymer topology characterization focused on cyclic polynorbornene produced with 2-TMS. as the M.sub.n (kDa) and dispersity () are most similar to those of linear polynorbornene synthesized with Grubbs' catalyst Ru(NHC(Ad)(Mes))(CH(PhOiPr))(2-NO.sub.3) (Mn 79.0 kDa, 2.84, >95% cis, >95% syndiotactic). Solution properties of cyclic polynorbornene were compared with those of linear norbornene via GPC analysis, providing evidence on the polymer cyclic topology. With a smaller hydrodynamic volume, cyclic polymers are expected to elute later than their linear counterparts, for a given molecular weight. As shown in the plot of log MW versus elution volume (
[0149] Formation of cyclic polynorbornene was confirmed by analyzing the intrinsic viscosity of the prepared polynorbornene in THF using a viscometer-equipped GPC. Due to their smaller overall dimensions, cyclic polymers are expected to exhibit lower intrinsic viscosity compared with analogous linear polymers for a given molecular weight. As shown in the Mark-Houwink-Sakurada plot in
[0150] Additionally, as shown in the plot of mean square radius of gyration (<R.sub.g.sup.2>) versus molar mass (
[0151] Thus, Example 5 demonstrates preparation of cyclic polymers using a catalyst of the disclosure and linear polymers using a catalyst not of the disclosure.
Example 6Evaluation of the Conversion of Catalysts 1-R to 2-R
[0152] Imido catalysts 2-R were observed to exhibit catalytic behavior in addition to the azoimido catalysts 1-R. The difference in activity between the 1-R and 2-R catalysts suggests the azoimido catalysts 1-R do not convert to imido catalysts 2-R under polymerization conditions. The conversion of azoimido catalyst 1-R into imido catalyst 2-R was evaluated via .sup.1H NMR spectroscopy and computational analysis.
[0153] The conversion of 1-R to 2-R was monitored with .sup.1H NMR spectroscopy to determine the rates of reaction and are shown in
[0154] Additionally, an Eyring analysis was carried out on catalyst 1-R to determine the enthalpy and entropy of activation for conversion to catalyst 2-R. For catalyst 1-Ph, the enthalpy and entropy of activation were H.sup.=23.4(0.5) kcal mol.sup.1 and S.sup.=9.8(1.4) cal mol.sup.1 K.sup.1, respectively. The negative activation entropy suggests an ordered transition state in the rate determining step. Table 3 lists the activation parameters for all 1-R.
TABLE-US-00005 TABLE 3 Experimental thermodynamic parameters for conversion of 1-R to 2-R calculated from Eyring equation. H.sup. S.sup. G.sup..sub.353K (kcal mol.sup.1) (cal mol.sup.1 K.sup.1) (kcal mol.sup.1) 1-Ph.sup.a 23.4 0.5 9.8 1.4 26.9 0.7 1-Oct.sup.b 26.6 2.7 3.9 7.8 27.9 3.9 1-Cy.sup.b 25.8 2.3 6.6 6.7 28.2 3.3 1-Bn.sup.b 29.3 1.2 0.6 3.4 29.1 1.7 .sup.aReported error bars are standard deviation calculated from three different data sets. .sup.bReported error bars are normal uncertainty in the data obtained from single data set.
[0155] The azido.fwdarw.imido transformation is thermodynamically favored due to the production of N.sub.2 gas. Consequently, the azoimido catalysts 1-R are expected to be thermodynamically unstable and have inherently low energy barriers for the transformation to the respective catalyst 2-R (Nguyen, A. I. Et al., Chem. Sci. 2011, 2, 166-189; Baek, Y. Et al., J. Am. Chem. Soc. 2020, 142, 11232-11243; Waterman, R. J. Am. Chem. Soc. 2008, 130, 12628-12629; Fickes, M. G. Et al., J. Am. Chem. Soc. 1995, 117, 6384-6385; Ison, E. A. Et al., J. Am. Chem. Soc. 2007, 129, 5, 1167-1178). Accordingly, the relative stability observed for catalyst 1-R was unexpected. (Wu, H. Et al. J. Am. Chem. Soc. 2008, 130, 16452-16453; Obenhuber, A. H. Et al., J. Am. Chem. Soc. 2014, 136, 2994-2997)
[0156] Among several postulated mechanisms, the simplest involves initial attack by the lone pair of the -N to the W(VI) center, forming a high energy 4-centered tungstatriazeto intermediate. This unstable intermediate then expels N.sub.2, forming a W(VI) imido via [2+2] retro-cycloaddition. In the case of 1-R, -N attack is predicted to occur in the upper (cis to alkylidene) or lower hemisphere (trans to the alkylidene) as shown in
[0157] DFT investigations were performed at the TPSSh-D0(SMD)/cc-pVTZ-(PP)//TPSSh/cc-pVDZ-(PP) level of theory to approximate the relative potential energy surface (PES) for the deazotation of catalyst 1-R. (Frisch, M. J. Et al., Gaussian 16, Revision C.01. Gaussian Inc., Wallingford CT 2016). These computational methods accurately reproduce experimental geometries and kinetic barriers of similar W-systems and match well with experimental solid-state parameters.
[0158]
[0159] THF dissociation again offers no apparent steric relief and conversely raises the calculated transition state barriers significantly (10 kcal mol.sup.1). Indeed, probing the influence of sterics on the barrier height by changing the alkylidene substituent from R=.sup.tBu to R=Me lowers the barriers for cis attack more significantly (6-9 kcal mol.sup.1) than those for trans attack (1-4 kcal/mol). Accordingly, trans attack remains rate limiting.
[0160] Both attack modes require a N-atom to move into the trans-position opposite the alkylidene. However, despite the clear open space, the N-atom always avoids linearity with the alkylidene and instead experiences a CWN140. This points to a strong trans-influence from the alkylidene as the new imido bond forms. Intrinsic bond orbital (IBO) analysis at the TPPSh/def2-TZVP level of theory calculates Wiberg bond indices (WBI), indicative of relative bond strengths during the reaction. Indeed, the double bond character of the WC.sub.alkylidene bond as measured by the WBI changes during the transformation and inversely mirrors the relative energies of barriers and intermediates along the reaction pathway almost exactly. Accordingly, WN multiple bonding in the transition state is inversely related to the strength of the alkylidene WC bond which contributes to the azoimido thermal stability.
[0161] Thus, example 6 demonstrates that the catalysts 1-R are unexpectedly stable and that catalysts 1-R do not convert into catalysts 2-R.
[0162] Many modifications and other embodiments will come to mind to one skilled in the art to which the disclosed compositions and methods pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the disclosures are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.